Time to move beyond retrospective analyses for thymic neoplasms and conduct a prospective multi-institutional clinical trial - Reply

被引:0
|
作者
Shrager, JB [1 ]
Kaiser, LR [1 ]
机构
[1] Univ Penn Hlth Syst, Hosp Univ Penn, Sect Gen Thorac Surg, Philadelphia, PA 19104 USA
来源
ANNALS OF THORACIC SURGERY | 2004年 / 78卷 / 06期
关键词
D O I
10.1016/j.athoracsur.2004.02.110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2207 / 2208
页数:2
相关论文
共 39 条
  • [21] Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial
    Dhall, Girish
    O'Neil, Sharon H.
    Ji, Lingyun
    Haley, Kelley
    Whitaker, Ashley M.
    Nelson, Marvin D.
    Gilles, Floyd
    Gardner, Sharon L.
    Allen, Jeffrey C.
    Cornelius, Albert S.
    Pradhan, Kamnesh
    Garvin, James H.
    Olshefski, Randal S.
    Hukin, Juliette
    Comito, Melanie
    Goldman, Stewart
    Atlas, Mark P.
    Walter, Andrew W.
    Sands, Stephen
    Sposto, Richard
    Finlay, Jonathan L.
    NEURO-ONCOLOGY, 2020, 22 (12) : 1862 - 1872
  • [22] Intermittent LHRH Therapy in the Management of Castrate-resistant Prostate Cancer (CRPCa) Results of a Multi-institutional Randomized Prospective Clinical Trial
    Organ, Michael
    Wood, Lori
    Wilke, Derek
    Skedgel, Chris
    Cheng, Tina
    North, Scott
    Thompson, Kara
    Winch, Susan
    Rendon, Ricardo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 601 - 605
  • [23] Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
    Pierorazio, Phillip M.
    Johnson, Michael H.
    Ball, Mark W.
    Gorin, Michael A.
    Trock, Bruce J.
    Chang, Peter
    Wagner, Andrew A.
    McKiernan, James M.
    Allaf, Mohamad E.
    EUROPEAN UROLOGY, 2015, 68 (03) : 408 - 415
  • [24] Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications DISCUSSION
    Matsumura, Jon
    Ozaki, C. Keith
    Lawrence, Peter
    Yu, David
    Eldrup-Jorgensen, Jens
    Chaar, Cassius Iyad Ochoa
    Shaw, Palma
    JOURNAL OF VASCULAR SURGERY, 2015, 61 (02) : 426 - 427
  • [25] Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries
    Mercado, Catherine E.
    Hartsell, William F.
    Simone, Charles B., II
    Tsai, Henry K.
    Vargas, Carlos E.
    Zhu, He J.
    Henderson, Randal H.
    Zeng, Jing
    Larson, Gary L.
    Hoppe, Bradford S.
    ACTA ONCOLOGICA, 2019, 58 (07) : 1036 - 1040
  • [26] Re: Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2016, 195 (02): : 297 - 298
  • [27] Stanford V chemotherapy and involved field radiotherapy for children and adolescents with unfavorable risk Hodgkin lymphoma: Results of a multi-institutional prospective clinical trial
    Metzger, Monika
    Billett, Amy
    Friedmann, Alison M.
    Krasin, Matthew J.
    Howard, Scott C.
    Weinstein, Howard J.
    Larsen, Eric
    Marcus, Karen Chayt
    Billups, Catherine
    Wu, Jianrong
    Donaldson, Sarah S.
    Link, Michael Paul
    Hudson, Melissa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Intermittent androgen-deprivation therapy in the management of castrate-resistant prostate cancer (CRPCa): Results of a multi-institutional randomized prospective clinical trial
    Organ, M.
    Wood, L.
    Wilke, D.
    Skedgel, C.
    Thompson, K.
    North, S.
    Cheng, T.
    Winch, S.
    Rendon, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [29] Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: A multi-institutional, phase II, prospective clinical trial.
    Aizer, Ayal
    Bi, Wenya Linda
    Catalano, Paul J.
    Chipidza, Fallon
    Haas-Kogan, Daphne A.
    Hertan, Lauren
    Kozono, David E.
    Krishnan, Monica
    Mak, Raymond H.
    Pashtan, Itai
    Peng, Luke
    Qian, Jack
    Rahman, Rifaquat
    Ricca, Ivy
    Sands, Jacob
    Shiloh, Ron Y.
    Shin, Kee-Young
    Tanguturi, Shyam Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Routine, prospective DPYD genotyping guided dose-individualisation for patients receiving fluoropyrimidines: Implementation, prevalence and patient safety outcomes from a multi-institutional clinical trial
    Nalder, Mark
    Kulasegaran, Tivya
    Lundie, Ben
    Woods, Rick
    Eastgate, Melissa A.
    Wyld, David
    Burge, Matthew E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)